1. Home
  2. CCCC vs LOVE Comparison

CCCC vs LOVE Comparison

Compare CCCC & LOVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCCC
  • LOVE
  • Stock Information
  • Founded
  • CCCC 2015
  • LOVE 1998
  • Country
  • CCCC United States
  • LOVE United States
  • Employees
  • CCCC N/A
  • LOVE N/A
  • Industry
  • CCCC Biotechnology: Pharmaceutical Preparations
  • LOVE Other Specialty Stores
  • Sector
  • CCCC Health Care
  • LOVE Consumer Discretionary
  • Exchange
  • CCCC Nasdaq
  • LOVE Nasdaq
  • Market Cap
  • CCCC 104.4M
  • LOVE 298.3M
  • IPO Year
  • CCCC 2020
  • LOVE 2018
  • Fundamental
  • Price
  • CCCC $2.26
  • LOVE $18.11
  • Analyst Decision
  • CCCC Buy
  • LOVE Strong Buy
  • Analyst Count
  • CCCC 3
  • LOVE 5
  • Target Price
  • CCCC $12.00
  • LOVE $30.40
  • AVG Volume (30 Days)
  • CCCC 1.6M
  • LOVE 403.9K
  • Earning Date
  • CCCC 07-31-2025
  • LOVE 06-12-2025
  • Dividend Yield
  • CCCC N/A
  • LOVE N/A
  • EPS Growth
  • CCCC N/A
  • LOVE N/A
  • EPS
  • CCCC N/A
  • LOVE 0.82
  • Revenue
  • CCCC $39,783,000.00
  • LOVE $686,358,000.00
  • Revenue This Year
  • CCCC N/A
  • LOVE $6.56
  • Revenue Next Year
  • CCCC N/A
  • LOVE $7.23
  • P/E Ratio
  • CCCC N/A
  • LOVE $22.23
  • Revenue Growth
  • CCCC 98.56
  • LOVE N/A
  • 52 Week Low
  • CCCC $1.09
  • LOVE $12.12
  • 52 Week High
  • CCCC $7.66
  • LOVE $39.49
  • Technical
  • Relative Strength Index (RSI)
  • CCCC 63.62
  • LOVE 44.31
  • Support Level
  • CCCC $1.36
  • LOVE $18.42
  • Resistance Level
  • CCCC $2.17
  • LOVE $19.41
  • Average True Range (ATR)
  • CCCC 0.15
  • LOVE 0.83
  • MACD
  • CCCC 0.05
  • LOVE 0.03
  • Stochastic Oscillator
  • CCCC 67.11
  • LOVE 13.56

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

About LOVE The Lovesac Company

The Lovesac Co designs, manufactures and sells alternative furniture which is comprised of modular couches called sactionals and premium foam beanbag chairs called sacs. It also offers other accessories such as sactional-specific drink holders, Footsac blankets, decorative pillows, fitted seat tables, and ottomans. Its products are sold across the United States through its website or company-owned retail stores which are used in homes and offices. The majority of the firm's revenue is derived from the sale of Sactionals.

Share on Social Networks: